Manufacturing model
Dermocosmetics manufacturing covers active-led products targeted at a specific skin concern, with verified efficacy and stability. KCM Pharma develops formulations around actives such as niacinamide, retinol, hyaluronic acid and salicylic acid, testing active stability, pH balance and skin compatibility so the product suits pharmacy, clinical and dermocosmetic channels.
A dermocosmetic's effect is determined not by active concentration alone but by the carrier system, the pH, and whether the active stays stable across shelf life. A high but unstable active does less than a lower, well-protected one. Our formulation work focuses on getting that balance right.
Retinol, vitamin C and several botanical actives are sensitive to light and oxygen. For these products, airless or opaque packaging is not a design preference but a technical requirement for the formula to keep working. We decide packaging alongside formulation.
The claims your product carries must be supportable by the test data you hold. We clarify which claim requires which test at the start, so you can build defensible communication without taking on unnecessary testing cost.
Choosing the right model is the decision that most affects a project's timeline and cost. The table below compares all four against the same criteria.
| Criterion | Contract | Private Label | Dermocosmetics | OEM / ODM |
|---|---|---|---|---|
| Formula source | Your formula, or developed exclusively for you | Ready formula library | Bespoke, active-led development | Concept developed by our R&D team |
| Typical timeline | 8–12 weeks | 6–10 weeks | 4–6 months | 3–5 months |
| What we need from you | A formula or a clear product definition | Category and brand direction | Target concern and claim | Target audience and price band |
| Distinctiveness | High | Medium | Very high | High |
| Best suited to | Brands with a settled product seeking capacity | A fast, low-risk first launch | Pharmacy and clinical channels, scientific claims | Brands seeking direction without R&D capacity |
Dermocosmetics are cosmetic products containing actives targeted at a specific skin concern, with supported efficacy. Legally both fall under cosmetics regulation; the difference lies in the formulation approach, active levels and usually the sales channel.
Regulation does not require efficacy testing for every product — the safety assessment is what is mandatory. However, if your product carries a specific efficacy claim, that claim must be supported by data.
The pharmacy channel usually asks for technical documents such as the product safety report, certificate of analysis and ingredient list. We prepare these alongside production.
We respond to quote requests within 24 hours.
Briefs and formulas you share are handled under a confidentiality agreement.
Other manufacturing models